ibuprofen 200
- Product NDC
- 0363-1517
- 11-digit product format
- 003631517
- Labeler code
- 0363
- Product ID
- 0363-1517_d7333eba-e5a2-4e80-aa6b-aa0102ebe6d4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ibuprofen
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Walgreen Company
- Application
- ANDA077349
- Marketing category
- ANDA
- Marketing start
- 2021-10-20
- Substance
- IBUPROFEN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ibuprofen 200
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IBUPROFEN | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WK2XYI10QM |
| Rxcui | 310965 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0363-1517-78 | ibuprofen 200 | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 4 |
| 0363-1517-78 | ibuprofen 200 | 1 in 1 CARTON | TABLET, FILM COATED | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0363-1517 | IBUPROFEN 200 (IBUPROFEN) TABLET, FILM COATED [WALGREEN COMPANY] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230425_49a3d51d-55d1-4b80-ab7b-35c27a937cb9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0363-1517-78 | 00363151778 | 1 BOTTLE in 1 CARTON (0363-1517-78) / 100 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2021-10-20 | 0000-00-00 | No | No | Current |